Nureca Limited IPO
Nureca Limited was a mainboard IPO in the Medical Equipment & Supplies sector, offered at ₹396–₹400 per share to raise ₹100 crore. The issue was subscribed 39.93× overall (QIBs 3.1×, NIIs 31.59×, retail 166.65×). It listed on 25 Feb 2021 at ₹615 and closed its first day at ₹646, a listing gain of +61.4% versus the ₹400 issue price. It now trades around ₹294 (-26.6% versus the issue price).
Frequently asked questions
- How many times was the Nureca Limited IPO subscribed?
- The Nureca Limited IPO was subscribed 39.93× overall — 3.1× in the QIB category, 31.59× among non-institutional investors, 166.65× in retail.
- What were the Nureca Limited IPO listing gains?
- Nureca Limited listed on 25 Feb 2021 at ₹615, closing its first day at ₹646 — a listing gain of +61.4% versus the ₹400 issue price.
- What were the retail allotment odds for the Nureca Limited IPO?
- Retail was subscribed 166.65×, so a single-lot application had roughly a 0.6% chance of allotment (about 1 in 167), and allotment was finalised on 19 Feb 2021.
- What was the price band and lot size of the Nureca Limited IPO?
- The price band was ₹396–₹400 per share, with a minimum lot of 35 shares (₹14,000 at the upper band).
- Who were the registrar and lead manager for the Nureca Limited IPO?
- Link Intime India Private Ltd was the registrar, and ITI Capital was the book-running lead manager.